除細動器の世界市場予測(~2027)

• 英文タイトル:Defibrillators Market Research Report by Type, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

Defibrillators Market Research Report by Type, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19「除細動器の世界市場予測(~2027)」(市場規模、市場予測)調査レポートです。• レポートコード:MRC2301C004
• 出版社/出版日:360iResearch / 2022年10月
• レポート形態:英語、PDF、254ページ
• 納品方法:Eメール(受注後2-3日)
• 産業分類:医療機器
• 販売価格(消費税別)
  Single User(1名利用、印刷可)¥742,350 (USD4,949)▷ お問い合わせ
  Enterprise License(企業利用、印刷可)¥1,492,350 (USD9,949)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
360iResearch社の本報告書によると、2021年に125.5億ドルであった世界の除細動器市場規模が、2022年に146.9億ドルになり、2027年まで年平均17.26%で成長して326.3億ドルに達すると予測されています。本資料では、除細動器の世界市場について調査・分析し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、種類別(体外式除細動器、植込み型除細動器)分析、エンドユーザー別(代替医療施設、在宅ケア、病院・診療所・心臓病センター、プレホスピタルケア)分析、地域別(南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他)分析、競争状況、企業情報などの構成でまとめています。なお、本レポートには、AMI Italia、Axion Ltd、Bexen Cardio、Biotronik SE & Co. KG、Boston Scientific Corporation、CU Medical Systems、Defibtech LLC、Fukuda Denshi Co. Ltd、Koninklijke Philips N.V.、LivaNova PLC、MEDIANA Co., Ltd、Medtronic Plc、Metrax GmbH、Metsis Medikal、MicroPort Scientific Corporation、Mindray Medical International Limited、MS Westfalen GmbHなどの企業情報があります。
・序論
・調査方法
・エグゼクティブサマリー
・市場概要
・市場インサイト
・世界の除細動器市場規模:種類別
- 体外式除細動器の市場規模
- 植込み型除細動器の市場規模
・世界の除細動器市場規模:エンドユーザー別
- 代替医療施設における市場規模
- 在宅ケアにおける市場規模
- 病院・診療所・心臓病センターにおける市場規模
- プレホスピタルケアにおける市場規模
・世界の除細動器市場規模:地域別
- 南北アメリカの除細動器市場規模
アメリカの除細動器市場規模
カナダの除細動器市場規模
ブラジルの除細動器市場規模
...
- アジア太平洋の除細動器市場規模
日本の除細動器市場規模
中国の除細動器市場規模
インドの除細動器市場規模
韓国の除細動器市場規模
台湾の除細動器市場規模
...
-ヨーロッパ/中東/アフリカの除細動器市場規模
イギリスの除細動器市場規模
ドイツの除細動器市場規模
フランスの除細動器市場規模
ロシアの除細動器市場規模
...
-その他地域の除細動器市場規模
・競争状況
・企業情報

The Global Defibrillators Market size was estimated at USD 12.55 billion in 2021 and expected to reach USD 14.69 billion in 2022, and is projected to grow at a CAGR 17.26% to reach USD 32.63 billion by 2027.

Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:
This research report categorizes the Defibrillators to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Type, the market was studied across External Defibrillators and Implantable Cardioverter Defibrillators. The Implantable Cardioverter Defibrillators is further studied across Subcutaneous Implantable Cardioverter Defibrillators and TransvenoSubcutaneous Implantable Cardioverter Defibrillators. The TransvenoSubcutaneous Implantable Cardioverter Defibrillators is further studied across Biventricular Icds/Cardiac Resynchronization Therapy Defibrillators, Dual-Chamber Icds, and Single-Chamber Icds.

Based on End User, the market was studied across Alternate Care Facilities, Home Care Settings, Hospitals, Clinics, & Cardiac Centers, Prehospital Care Settings, and Public Access Markets.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Defibrillators market considering the current update on the conflict and its global response.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Defibrillators Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Defibrillators Market, including AMI Italia, Axion Ltd, Bexen Cardio, Biotronik SE & Co. KG, Boston Scientific Corporation, CU Medical Systems, Defibtech LLC, Fukuda Denshi Co. Ltd, Koninklijke Philips N.V., LivaNova PLC, MEDIANA Co., Ltd, Medtronic Plc, Metrax GmbH, Metsis Medikal, MicroPort Scientific Corporation, Mindray Medical International Limited, MS Westfalen GmbH, Narang Medical Limited, Nihon Kohden Corporation, Physio-Control Corporation, Progetti Srl, Schiller AG, and ST. Jude Medical.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Defibrillators Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Defibrillators Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Defibrillators Market?
4. What is the competitive strategic window for opportunities in the Global Defibrillators Market?
5. What are the technology trends and regulatory frameworks in the Global Defibrillators Market?
6. What is the market share of the leading vendors in the Global Defibrillators Market?
7. What modes and strategic moves are considered suitable for entering the Global Defibrillators Market?

レポート目次

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Surging incidences of cardiac disorders
5.1.1.2. Rising availability of defibrillators for the public coupled with training and awareness programs
5.1.1.3. Favorable supportive regulations and rising adoption of defibrillators
5.1.2. Restraints
5.1.2.1. Concerns pertinent to application of implantable and automated external defibrillators
5.1.3. Opportunities
5.1.3.1. Ongoing development of S-ICDs and MRI-compatible and CRT-Ds
5.1.3.2. Emerging demand for automated external defibrillators in prehospital environment
5.1.4. Challenges
5.1.4.1. Failure or frequent product recalls
5.2. Cumulative Impact of COVID-19

6. Defibrillators Market, by Type
6.1. Introduction
6.2. External Defibrillators
6.3. Implantable Cardioverter Defibrillators
6.4.1. Subcutaneous Implantable Cardioverter Defibrillators
6.4.2. TransvenoSubcutaneous Implantable Cardioverter Defibrillators
6.4.3.1. Biventricular Icds/Cardiac Resynchronization Therapy Defibrillators
6.4.3.2. Dual-Chamber Icds
6.4.3.3. Single-Chamber Icds

7. Defibrillators Market, by End User
7.1. Introduction
7.2. Alternate Care Facilities
7.3. Home Care Settings
7.4. Hospitals, Clinics, & Cardiac Centers
7.5. Prehospital Care Settings
7.6. Public Access Markets

8. Americas Defibrillators Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Defibrillators Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Defibrillators Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis, By Key Player
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles
12.1. AMI Italia
12.1.1. Business Overview
12.1.2. Key Executives
12.1.3. Product & Services
12.2. Axion Ltd
12.2.1. Business Overview
12.2.2. Key Executives
12.2.3. Product & Services
12.3. Bexen Cardio
12.3.1. Business Overview
12.3.2. Key Executives
12.3.3. Product & Services
12.4. Biotronik SE & Co. KG
12.4.1. Business Overview
12.4.2. Key Executives
12.4.3. Product & Services
12.5. Boston Scientific Corporation
12.5.1. Business Overview
12.5.2. Key Executives
12.5.3. Product & Services
12.6. CU Medical Systems
12.6.1. Business Overview
12.6.2. Key Executives
12.6.3. Product & Services
12.7. Defibtech LLC
12.7.1. Business Overview
12.7.2. Key Executives
12.7.3. Product & Services
12.8. Fukuda Denshi Co. Ltd
12.8.1. Business Overview
12.8.2. Key Executives
12.8.3. Product & Services
12.9. Koninklijke Philips N.V.
12.9.1. Business Overview
12.9.2. Key Executives
12.9.3. Product & Services
12.10. LivaNova PLC
12.10.1. Business Overview
12.10.2. Key Executives
12.10.3. Product & Services
12.11. MEDIANA Co., Ltd
12.11.1. Business Overview
12.11.2. Key Executives
12.11.3. Product & Services
12.12. Medtronic Plc
12.12.1. Business Overview
12.12.2. Key Executives
12.12.3. Product & Services
12.13. Metrax GmbH
12.13.1. Business Overview
12.13.2. Key Executives
12.13.3. Product & Services
12.14. Metsis Medikal
12.14.1. Business Overview
12.14.2. Key Executives
12.14.3. Product & Services
12.15. MicroPort Scientific Corporation
12.15.1. Business Overview
12.15.2. Key Executives
12.15.3. Product & Services
12.16. Mindray Medical International Limited
12.16.1. Business Overview
12.16.2. Key Executives
12.16.3. Product & Services
12.17. MS Westfalen GmbH
12.17.1. Business Overview
12.17.2. Key Executives
12.17.3. Product & Services
12.18. Narang Medical Limited
12.18.1. Business Overview
12.18.2. Key Executives
12.18.3. Product & Services
12.19. Nihon Kohden Corporation
12.19.1. Business Overview
12.19.2. Key Executives
12.19.3. Product & Services
12.20. Physio-Control Corporation
12.20.1. Business Overview
12.20.2. Key Executives
12.20.3. Product & Services
12.21. Progetti Srl
12.21.1. Business Overview
12.21.2. Key Executives
12.21.3. Product & Services
12.22. Schiller AG
12.22.1. Business Overview
12.22.2. Key Executives
12.22.3. Product & Services
12.23. ST. Jude Medical
12.23.1. Business Overview
12.23.2. Key Executives
12.23.3. Product & Services

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing




• 英文レポート名:Defibrillators Market Research Report by Type, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
• 日本語訳:除細動器の世界市場予測(~2027)
• レポートコード:MRC2301C004お問い合わせ(見積依頼・ご注文・質問)